Oncological outcomes of neoadjuvant chemotherapy in patients with locally advanced upper tract urothelial carcinoma: A multicenter study. Enfortumab vedotin (EV) in patients (Pts) with metastatic ...
Final analysis results from a multicenter clinical study of tislelizumab combined with gemcitabine and cisplatin as neoadjuvant therapy in patients with cT2-T4aN0M0 MIBC. This is an ASCO Meeting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results